No Data
No Data
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins FuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
Inozyme Draws Buy at Jefferies on Rare Disease Opportunity
Jefferies Initiates Inozyme Pharma(INZY.US) With Buy Rating, Announces Target Price $17
Inozyme Pharma: A Buy Rating With Multi-Billion Dollar Market Potential and Upcoming Catalysts
Express News | Inozyme Pharma Inc : Jefferies Assumes Coverage With Buy Rating; Target Price $17 Vs $16